Abstract

Cells harbor two systems for fatty acid synthesis, one in the cytoplasm (catalyzed by fatty acid synthase, FASN) and one in the mitochondria (mtFAS). In contrast to FASN, mtFAS is poorly characterized, especially in higher eukaryotes, with the major product(s), metabolic roles, and cellular function(s) being essentially unknown. Here we show that hypomorphic mtFAS mutant mouse skeletal myoblast cell lines display a severe loss of electron transport chain (ETC) complexes and exhibit compensatory metabolic activities including reductive carboxylation. This effect on ETC complexes appears to be independent of protein lipoylation, the best characterized function of mtFAS, as mutants lacking lipoylation have an intact ETC. Finally, mtFAS impairment blocks the differentiation of skeletal myoblasts in vitro. Together, these data suggest that ETC activity in mammals is profoundly controlled by mtFAS function, thereby connecting anabolic fatty acid synthesis with the oxidation of carbon fuels.

Data availability

The data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository. The code used to process these data is available at Github https://github.com/j-berg/nowinski_2020.Sequencing data have been deposited at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE148617

The following data sets were generated

Article and author information

Author details

  1. Sara M Nowinski

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  2. Ashley Solmonson

    Children's Research Institute, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8863-4558
  3. Scott F Rusin

    Department of Cell Biology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  4. J Alan Maschek

    Nutrition and Integrative Physiology, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  5. Claire L Bensard

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  6. Sarah Fogarty

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  7. Mi-Young Jeong

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  8. Sandra Lettlova

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  9. Jordan A Berg

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  10. Jeffrey T Morgan

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  11. Yeyun Ouyang

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  12. Bradley C Naylor

    Metabolomics, Proteomics, and Mass Spectrometry Core, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  13. Joao A Paulo

    Department of Cell Biology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  14. Katsuhiko Funai

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  15. James E Cox

    Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  16. Steven P Gygi

    Department of Cell Biology, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  17. Dennis R Winge

    Department of Medicine, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1160-1189
  18. Ralph J DeBerardinis

    Children's Research Institute, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    Ralph J DeBerardinis, Reviewing editor, eLife.
  19. Jared Rutter

    Biochemistry, University of Utah, Salt Lake City, United States
    For correspondence
    rutter@biochem.utah.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2710-9765

Funding

National Institute of General Medical Sciences (GM115174)

  • Jared Rutter

National Cancer Institute (R35CA22044901)

  • Ralph J DeBerardinis

The Once Upon a Time Foundation

  • Ralph J DeBerardinis

Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD096786)

  • Ashley Solmonson

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107397)

  • Katsuhiko Funai

National Institute of Diabetes and Digestive and Kidney Diseases (R21AG063077)

  • Katsuhiko Funai

Office of the Director (S10OD016232)

  • James E Cox

Office of the Director (S10OD021505)

  • James E Cox

National Institute of Diabetes and Digestive and Kidney Diseases (U54DK110858)

  • James E Cox

National Institute of General Medical Sciences (R01GM132129)

  • Joao A Paulo

National Institute of General Medical Sciences (GM97645)

  • Steven P Gygi

National Institute of General Medical Sciences (GM115129)

  • Jared Rutter

National Institute of General Medical Sciences (GM110755)

  • Dennis R Winge

The Nora Eccles Treadwell Foundation

  • Jared Rutter

Howard Hughes Medical Institute (Investigator)

  • Jared Rutter

United Mitochondrial Disease Foundation (PF-15-046)

  • Sara M Nowinski

American Cancer Society (PF-18-106-01)

  • Sara M Nowinski

National Heart, Lung, and Blood Institute (T32HL007576)

  • Sara M Nowinski

National Institute of Diabetes and Digestive and Kidney Diseases (T32DK11096601)

  • Jordan A Berg

Howard Hughes Medical Institute (Investigator)

  • Ralph J DeBerardinis

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Nowinski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 12,110
    views
  • 1,547
    downloads
  • 81
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sara M Nowinski
  2. Ashley Solmonson
  3. Scott F Rusin
  4. J Alan Maschek
  5. Claire L Bensard
  6. Sarah Fogarty
  7. Mi-Young Jeong
  8. Sandra Lettlova
  9. Jordan A Berg
  10. Jeffrey T Morgan
  11. Yeyun Ouyang
  12. Bradley C Naylor
  13. Joao A Paulo
  14. Katsuhiko Funai
  15. James E Cox
  16. Steven P Gygi
  17. Dennis R Winge
  18. Ralph J DeBerardinis
  19. Jared Rutter
(2020)
Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria
eLife 9:e58041.
https://doi.org/10.7554/eLife.58041

Share this article

https://doi.org/10.7554/eLife.58041

Further reading

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Flavie Coquel, Sing-Zong Ho ... Philippe Pasero
    Research Article

    Cancer cells display high levels of oncogene-induced replication stress (RS) and rely on DNA damage checkpoint for viability. This feature is exploited by cancer therapies to either increase RS to unbearable levels or inhibit checkpoint kinases involved in the DNA damage response. Thus far, treatments that combine these two strategies have shown promise but also have severe adverse effects. To identify novel, better-tolerated anticancer combinations, we screened a collection of plant extracts and found two natural compounds from the plant, Psoralea corylifolia, that synergistically inhibit cancer cell proliferation. Bakuchiol inhibited DNA replication and activated the checkpoint kinase CHK1 by targeting DNA polymerases. Isobavachalcone interfered with DNA double-strand break repair by inhibiting the checkpoint kinase CHK2 and DNA end resection. The combination of bakuchiol and isobavachalcone synergistically inhibited cancer cell proliferation in vitro. Importantly, it also prevented tumor development in xenografted NOD/SCID mice. The synergistic effect of inhibiting DNA replication and CHK2 signaling identifies a vulnerability of cancer cells that might be exploited by using clinically approved inhibitors in novel combination therapies.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.